Neogen (NEOG) Free Cash Flow (QoQ) (2010 - 2026)
Neogen (NEOG) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Neogen | 2.08 Bn | 1.92 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 42.43% |
| Nov 30, 2025 | 159.13% |
| Aug 31, 2025 | -3,867.62% |
| May 31, 2025 | 102.59% |
| Feb 28, 2025 | -158.23% |
| Nov 30, 2024 | 140.99% |
| Aug 31, 2024 | -2,360.21% |
| May 31, 2024 | 104.00% |
| Feb 29, 2024 | -616.24% |
| Nov 30, 2023 | -14.18% |
| Aug 31, 2023 | -111.64% |
| May 31, 2023 | 303.17% |
| Feb 28, 2023 | -4.50% |
| Nov 30, 2022 | -13.61% |
| Aug 31, 2022 | -445.63% |
| May 31, 2022 | 12,180.00% |
| Feb 28, 2022 | -100.47% |
| Nov 30, 2021 | -36.54% |
| Aug 31, 2021 | 49.59% |
| May 31, 2021 | 344.61% |